Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | MAOB | P27338 | 2/20 | 0.52 |
| ▸ | MAPKAPK2 | P49137 | 8/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7970202 | 0.83 | MAOA (0.55) | MAOAMAOBMAPKAPK2NPC1LMNA | |
| SCHEMBL1461767 | 0.83 | MAPKAPK2 (0.57) | MAOAMAOBMAPKAPK2NPC1LMNA | |
| SCHEMBL1979796 | 0.80 | MAOA (0.52) | MAOAMAOBMAPKAPK2NPC1LMNA | |
| SCHEMBL1980248 | 0.79 | MAOA (0.59) | MAOAMAOBMAPKAPK2NPC1LMNA | |
| Bromide SCHEMBL6129306 | 0.77 | MAOA (0.57) | MAOAMAOBMAPKAPK2NPC1LMNA | |
| SCHEMBL88260 | 0.75 | MAOA (0.59) | MAOAMAOBMAPKAPK2NPC1LMNA | |
| SCHEMBL31470407 | 0.75 | MAOA (0.59) | MAOAMAOBMAPKAPK2NPC1LMNA | |
| SCHEMBL29453995 | 0.74 | MAOA (0.64) | MAOAMAOBMAPKAPK2NPC1LMNA | |
| Hydrochloric Acid SCHEMBL28586545 | 0.74 | MAOA (0.57) | MAOAMAOBMAPKAPK2NPC1LMNA | |
| SCHEMBL6667007 | 0.72 | MAOA (0.46) | MAOAMAOBMAPKAPK2NPC1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160354533-A1 | ADSORBING PATHOGEN-INACTIVATING COMPOUNDS WITH POROUS PARTICLES IMMOBILIZED IN A MATRIX | CERUS CORPORATION (US) | 2016-12-08 | — | — | US | disclosed |
| US-9259525-B2 | Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix | CERUS CORPORATION (US) | 2016-02-16 | — | — | US | disclosed |
| EP-2358814-B1 | PLASTICIZER FOR THERMOPLASTIC POLYMER MATERIALS | AVENT INC (US) | 2015-07-29 | — | — | EP | disclosed |
| EP-1508345-B1 | System and method for the reduction of small organic compounds from blood products | CERUS CORP (US) | 2013-09-25 | — | — | EP | disclosed |
| US-8518315-B2 | Plasticizer for thermoplastic materials | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2013-08-27 | — | — | US | disclosed |
| EP-2358814-A2 | PLASTICIZER FOR THERMOPLASTIC POLYMER MATERIALS | Kimberly-Clark Worldwide, Inc. (US) | 2011-08-24 | — | — | EP | disclosed |
| US-20110143621-A1 | PLASTICIZER FOR THERMOPLASTIC POLYMER MATERIALS | AVANOS MEDICAL SALES, LLC | 2011-06-16 | — | — | US | disclosed |
| WO-2010070524-A2 | XANTHENE-BASED PLASTICIZER OF RESINS AND POLYMERS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2010-06-24 | — | — | WO | disclosed |
| US-20100160484-A1 | XANTHENE-BASED PLASTICIZER OF RESINS AND POLYMERS | AVANOS MEDICAL SALES, LLC | 2010-06-24 | — | — | US | disclosed |
| US-20100159769-A1 | PLASTICIZER FOR THERMOPLASTIC MATERIALS | AVANOS MEDICAL SALES, LLC | 2010-06-24 | — | — | US | disclosed |
| EP-1044066-A1 | BATCH DEVICES FOR THE REDUCTION OF COMPOUNDS FROM BIOLOGICAL COMPOSITIONS CONTAINING CELLS AND METHODS OF USE | Cerus Corporation (US) | 2000-10-18 | — | — | EP | disclosed |
| CN-1248178-A | Method and device for reducing small organic molecules in blood products | CERUS CORP (US) | 2000-03-22 | — | — | CN | disclosed |
| EP-0954374-A1 | METHODS AND DEVICES FOR THE REDUCTION OF SMALL ORGANIC COMPOUNDS FROM BLOOD PRODUCTS | Cerus Corporation (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1999034914-A1 | BATCH DEVICES FOR THE REDUCTION OF COMPOUNDS FROM BIOLOGICAL COMPOSITIONS CONTAINING CELLS AND METHODS OF USE | CERUS CORPORATION (US) | 1999-07-15 | — | — | WO | disclosed |
| WO-1999034915-A1 | FLOW DEVICES FOR THE REDUCTION OF COMPOUNDS FROM BIOLOGICAL COMPOSITIONS AND METHODS OF USE | CERUS CORPORATION (US) | 1999-07-15 | — | — | WO | disclosed |
| WO-1998030327-A1 | METHODS AND DEVICES FOR THE REDUCTION OF SMALL ORGANIC COMPOUNDS FROM BLOOD PRODUCTS | CERUS CORPORATION (US) | 1998-07-16 | — | — | WO | disclosed |
| EP-0471794-B1 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES | OKLAHOMA MED RES FOUND (US) | 1996-10-02 | — | — | EP | disclosed |
| EP-0471794-A4 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES | — | 1992-05-06 | — | — | EP | disclosed |
| EP-0471794-A1 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES. | OKLAHOMA MED RES FOUND (US) | 1992-02-26 | — | — | EP | disclosed |
| WO-1990013296-A1 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1990-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160484-A1 | XANTHENE-BASED PLASTICIZER OF RESINS AND POLYMERS | SMARCA2, SMARCA1, MYB | MAOA 1730/4885MAOB 2569/4885MAPKAPK2 4256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.